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Introduction
 Imaging-guided core needle biopsy (CNB) could be 
a reliable method for evaluating breast masses. Limited 
core sample specimen by CNB could miss atypical ductal 
hyperplasia (ADH) that include breast cancer portion 
within the breast lesion. Hence, surgical excisional biopsy 
or operation has been considered, even when ADHs are 
diagnosed at CNB because 23-65% of those lesions 
were upgraded to DCIS or IDC when revaluated after 
operation (Jang et al., 2008; Chae et al., 2009). And DCIS 
underestimation occurs in CNB, which means a lesion 
yields DCIS at percutaneous breast needle biopsy with 
revealing invasive cancer at surgery (Suh et al., 2012). 
DCIS underestimation is probably due to sampling error 
in a lesion that contains both DCIS and IDC. 
 Previous studies have suggested underestimation 
rates ranging from 6.25% to 65% for ADH and the 
underestimation rates of DCIS were from 16% to 66% 
by using various guiding methods including CNB or 
breast biopsy with vacuum assisted device (Crystal et 
al., 2005; Jang et al., 2008; Suh et al., 2012; Lee et al., 
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2013). There has been several studies about correlation 
with underestimation rate and clinical condition or 
radiologic findings such as Breast US or mammogram. 
Some study was evaluated to develop a scoring system 
for prediction of ADH underestimation at sonographically 
guided CNB (Ko et al., 2008). Sonographic BI-RADS final 
assessment categories were not significantly associated 
with underestimation, but detailed sonographic features 
according to the BI-RADS lexicon were not analyzed. 
 Youk et al. (2009) reported that US-guided CNB had 
a high underestimation of ADH with subsequent excision 
and there also was no clinical or radiological values 
including lesion characteristics and BI-RADS categories 
at mammography and sonography predicting upgrade to 
malignancy (Youk et al., 2009). And there have been recent 
report about the comparisons between the underestimated 
breast lesions and accurately diagnosed breast lesion, 
especially ADH in US-guided 14G CNB with subsequent 
excision (Hsu et al., 2012). So, when pathologic result 
revealed breast cancer with US-guided 14G CNB, our 
investigation was undertaken to compare the clinical and 
radiologic features between the underestimated breast 
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cancer and accurately diagnosed breast cancer.
 The purpose of our study was to determine the 
underestimation rate of US-guided 14G CNB and reveal 
the ultrasonography (US) and mammographic features of 
breast cancers, which was underestimated or accurately 
diagnosed by US-guided CNB and to compare of clinical 
and radiologic findings between underestimated and 
accurately diagnosed breast cancer.
 
Materials and Methods
Study population
 Our institutional review board approved this 
retrospective observational study, and informed consent 
was not required from patients. Informed consent for 
all percutaneous biopsy procedures was obtained from 
all patients prior to biopsy. Between January 2007 and 
December 2009, percutaneous US-guided 14-gauge 
CNB was performed on 1898 consecutive breast lesions 
at our institution. Among the 1898 lesions, the 233 cases 
were surgical proved as breast cancer. Retrospectively, 
pathologic results on CNB were breast cancer in 197 cases, 
high-risk lesions in 22 cases, and benign in 14 cases (which 
were false negative results and excluded on this study). 
Among the CNB proven high-risk lesions, pathologic 
result revealed ADH (n=7) and other high-risk lesions 
(such as papillary lesion with atypia (n=10) or phyllodes 
tumors (n=4) or lobular neoplasm (n=1), which were 
potentially malignant lesion, but also debates for aspect 
of definition of underestimated cancer and so excluded on 
this study, n=15). 
 Among the CNB proven breast cancer, IDC (n=157) 
and DCIS (n=40) were reported. Surgically pathologic 
results of CNB proven DCIS cases were IDC (n=11) and 
DCIS, itself (n=29). So we included indication of cases 
about CNB proven ADH (n=7), CNB proven DCIS (n=40) 
or IDC (n=157) and categorized as underestimated breast 
cancer including 7 cases, which were ADH though CNB 
but final diagnosed at DCIS or IDC and 11 cases, which 
were DCIS by CNB and final diagnosed at IDC (total 
n=18) and accurately breast diagnosed cancer including 
157 cases, proven IDC by CNB and 29 cases, proven DCIS 
with final diagnosed also DCIS (total n=186) (Figure 1). 
US were available in all patients and mammograms of 12 
of the 18 patients in underestimated breast cancer group 
and 149 of the 186 patients in accurately diagnosed breast 
cancer group were available. 
Imaging and biopsy technique
 Breast ultrasonography was performed with high 
resolution sonography unit with 7.5 or 12-MHz linear 
array transducers (ATL HDI 5000 or IU-22, Philips-
Advanced Technology Laboratories, Bothell, WA, USA). 
The mammography was done with GE Senographe 2000D 
(GE Medical Systems, Milwaukee, WI, USA). US-guided 
CNBs were performed using a free-hand technique with 
a 14-gauge semi-automated core biopsy needle (Stericut, 
TSK, Japan). 
 US and biopsies were performed by one of 3 
radiologists with fellowship training (n=1) or experienced 
radiologist in breast imaging and biopsy (n=2, each 
Figure 1. Pathologic Results of US-Guided 14 Core 
Needle Biopsy-
were 10 and 6 years of experiences). According to our 
standard protocol, five or six core samples were obtained, 
and the appearance of the formalin-fixed core samples 
were examined during the procedure to confirm that 
the targeted lesion was sampled adequately. Prior to 
biopsy, mammographic and sonographic findings were 
categorized according to BI-RADS, and the data were 
entered into a database using a computerized spreadsheet 
(Excel, Microsoft, Redmond, WA). The CNB results were 
divided into malignant, high-risk, and benign according 
to the pathologic report. We recommended definitive 
treatment for malignant lesions and advised excision for 
high-risk lesions. 
Imaging review and analysis 
 After review of the surgical and CNB histologic 
findings, we categorized as accurately diagnosed breast 
cancer or underestimated breast cancer and the rate of 
underestimation was assessed. For each lesion, medical 
records, image findings of mammograms and sonograms 
also were reviewed, and clinical and radiologic variables 
were coded. The collected clinical variables were as 
follows: age, personal history of breast cancer, and 
associated symptoms. For collection of radiologic 
variables, each image was reviewed retrospectively by 
two radiologists (H. N. K and E. J. S) who were blinded 
to biopsy and operation pathology with consensus. 
 The prospectively assigned mammographic and 
sonographic BI-RADS categories were documented. We 
have subclassified or divided as category 4 into categories 
4a, 4b, and 4c and recorded at data sheets. Mammographic 
visibility of the lesion such as focal asymmetry or 
asymmetry and lesion type (shape, margin and density 
of mass and calcification shape and distribution) were 
evaluated. The following sonographic features were 
determined according to the terminology of the American 
College of Radiology BI-RADS lexicon (American 
College of Radiology, 2003) such as shape, orientation, 
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depth, margin, echogenicity, calcification and multiplicity. 
Data analysis
 The underestimated and the accurately diagnosed 
breast cancer were compared in terms of mammographic 
and US features, the size of lesion (as measured on the 
longest sonographic diameter), and tumor location and 
patient’s age, symptom and history. Data were analyzed 
using the Chi-square test for nonparametric variables and 
the t-test for parametric variables. Statistical significance 
was indicated by a p value less than 0.05. All data was 
processed with commercially available software using 
the SYSTAT, version 5.2, statistical package (Systat, 
Evanston, IL).
Results 
 Of 233 cases of cancer, underestimation occurred in 18 
lesions at percutaneous US-guided 14-gauge CNB (7.7%). 
Among the 18 underestimated breast cancers, the CNB 
results were: ADH (n=7) and DCIS (n=11) which were 
DCIS or IDC in final pathology (Figure 1). 
 The analysis of clinical variables is summarized in 
Table 1. The mean age of the patients was 46.1±14.5 
years (range, 21-77 years), 50.6 years for patients with 
underestimated breast cancer and 49.1 years for those 
with accurately diagnosed breast cancer (p=0.53). One 
patient (6%) among the underestimated cancer group 
and 10 patients (5%) among the accurately diagnosed 
breast cancer group had a personal history of cancer of 
the contralateral breast. In terms of associated symptoms 
or past history, there was no statistically significant 
differences were found in between underestimated and 
accurately diagnosed group (p=0.57, p=0.31). 
 The analysis of mammographic findings is summarized 
in Table 2. All lesions were classified as BI-RADS 
category. Relatively high BI-RADS categories was noted 
in accurately diagnosed breast cancer (p=0.01). Margin of 
mass on mammography revealed statistically significant 
difference between two groups (p=0.01). There was no 
statistically significant difference in asymmetry, shape 
and density of mass, presence of calcifications, shape and 
distribution of calcifications in between underestimation 
and accurately diagnosed group.
 Table 3 summarizes the sonographic features of 
Table 2. Comparision of Underestimated and 
Accurately Diagnosed Breast Cancer: Mammographic 
Findingss
Variable Underestimated Accurately p value
 breast cancer diagnosed 
  breast cancer
 (n=12) (n=149)
Category    0.01
0/1/2/3  4/1/0/1 22/0/0/0 
4a/b/c  0/2/0 0/15/17 
5  4 95 
Focal asymmetry 2 15 0.72
Asymmetry  0 1 
Mass  6 126 
Shape Round 3 21 0.55
 Oval 0 2 
 Lobular 0 7 
 Irregular 3 96 
Margin Circumscribed 1 7 0.01
 Microlobulated 2 5 
 Obscured 1 3 
 Lobular 0 19 
 Indisctinct 0 0 
 Spiculated 2 92 
Density High 6 124 0.33
 Iso 0 2 
 Low 0 0 
Calcification Yes 7 67 0.36
 No 5 82 
Shape Plemorphic 6 65 0.16
 Amorphos 1 2 
Distribution Clustered 3 51 0.13
 Linear 0 0 
 Lobular 0 0 
 Branching 0 0 
 Segmental 3 16 
 Diffuse 1 0 
Table 1. Comparision of Underestimated and 
Accurately Diagnosed Breast Cancer: Clinical 
Variables
Variable Underestimated Accurately p value
 breast cancer diagnosed 
  breast cancer
 (n=18) (n=186)
Age 30-50 11 103 0.53
 51-70 7 83 
Past history No 15 169 0.57
 Breast cancer 1 10 
 Benign breast mass 2 7 
Associated symptom Palpable 10 95 0.31
 Nipple discharge 3 6 
 Pain 1 13 
 No 4 68 
 Axillary mass 0 4 
Table 3. Comparision of Underestimated and Accurately 
Diagnosed Breast Cancer: Ultrasonographic Findings
Variable Underestimated Accurately p value
 breast cancer diagnosed 
  breast cancer
 (n=18) (n=186)
Category    0.01
4a/b/c  7/8/1 12/19/25 
5  2 130 
6  0 0 
Size <10 4 24 0.49
 ≥10 14 162 
Location Right 11 88 0.46
 Left 7 98 
Shape Oval 2 21 0.35
 Round 4 29 
 Irregular 12 136 
Orientation Parallel 15 71 0.01
 Non-Parallel 3 115 
Depth Superficial 5 19 0.43
 Mid 12 145 
 Deep 1 22 
Margin Circumscribed 2 14 0.01
 Indistinct 5 9 
 Angular 3 0 
 Microlobulated 8 51 
 Spiculated 0 112 
Echogenicity Anechoic 0 0 0.67
 Hyperechoic 0 8 
 Complex 1 19 
 Hypoechoic 11 158 
 Isoechoic 6 1 
Calcification No 13 151 0.93
 Micocalcification 3 35 
 Macrocalcification 2 0 
Multiplicity No 8 137 0.52
 Yes 10 49 
all lesions according to BI-RADS descriptions. The 
mean diameter of the lesions measured at sonography 
was 31.9±9.2mm (range, 5-100mm), 37.5mm for 
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27 lesions). Our results showed no significant difference 
in the sizes, clinical variables such as patient’s age, past 
history and associated symptom between underestimated 
and accurately diagnosed cases. So underestimation rate 
using US-guided CNB could be not related with clinical 
condition.
Some reports show that almost underestimated 
breast cancers (93%) with vacuum suction biopsy were 
reported as calcifications on mammogram (Philpotts et 
al., 2000). Our study suggest that the underestimation 
rate for calcifications were 9.4% (7/74) on mammogram 
and 12.5% (5/40) on US imaging, although we could not 
have targeted calcification only lesion on US imaging. 
But, our results showed no statistically significant 
difference about calcification on mammogram or US 
between underestimated and accurately diagnosed 
breast cancer groups (p=0.36, 0.93). The current study 
evaluated radiologic findings with DCIS or subtype of 
DCIS such as DCIS with microinvasion (positivity of 
sentinel lymph node biopsy), distinguishing in situ disease 
from microinvasive disease. There was no significant 
difference in the rates of microcalcifications or mass 
lesions on mammogram between the DCIS and DCIS with 
microinvasion patients. Further investigation with a larger 
patient database could be needed for better evaluating 
factors to characterize the potential microinvasion of 
DCIS among the patients with CNB proven DCIS (Ozkan-
Gurdal et al., 2014)
And our study showed that there were significantly 
differences for BIRADS category and margin of mass on 
mammogram in comparison between underestimated and 
accurately diagnosed breast cancer (p=0.01). For example, 
underestimation rate for microlobulated or obscured 
margin was in 28.5% (2/7) and 25% (1/4) on mammogram.
On US finding, margin of mass and orientation of mass 
on US showed significantly differences in comparison 
between underestimated and accurately diagnosed 
breast cancer (p=0.01). For example, underestimation 
rate for indistinct margin on US was 35.7% (5/14) on 
US. Interesting points were underestimation rates for 
non-parallel mass and parallel mass in 2.5% (3/118) and 
17.4% (15/86) on US imaging. These radiologic findings 
affect results of BI-RADS category in two groups, so 
relatively lower BI-RADS category on underestimated 
breast cancer was described, compared with correctly 
diagnosed breast cancer. It means relatively pathologic 
finding of inherent ambiguity of ADH or DCIS, which is 
lack of stromal invasion area, could affect low suspicious 
finding, attributable with lower BIRAD category such as 
1, 2, 3 and 4a on US and mammogram. 
Our study had several limitations. First, this 
retrospective analysis was limited by the small sample 
size. Further investigation with a larger patient database is 
necessary to ascertain the factors, related to underestimation 
of US-guided CNB. Second, other borderline or high rick 
lesions such as papillary lesion with atypia or phyllodes 
tumor were excluded at underestimated breast cancer 
group without any explanation. These kinds of pathology 
entities should be considered further investigation. Finally 
there might have been selection bias, because surgically 
excised lesions with US-guided CNB at the same time on 
Table 4. Comparision of Underestimated and 
Accurately Diagnosed Breast Cancer: Clinical 
Variables
Researchers Underestimation Researchers Underestimation 
  of ADH (%)  of DCIS (%)
14-gauge US guided core needle biopsy
 Jang et al., 2008 65 Suh et al., 2012 47.8
 Youk et al., 2009 62 Sauer et al., 2005 61.1
 Crystal et al., 2005 50 Crystal et al., 2005 66.7
 Ko et al., 2008 45.8 Youk at al., 2008 29
 Hsu et al., 2012 40 Wiratkapun et al., 2012 47
 Chae et al., 2009 23.1 This study 40.7
 This study 53.8  
 Wiratkapun et al., 2012 40  
11-gauge US guided vacuum assisted biopsy 
 Jang et al., 2008 22 Cassano et al., 2007 16.7
 Chae et al., 2009 16.7  
11-gauge stereotatic vacuum assisted biopsy
 Lee et al., 2013 6.25 Suh et al., 2012* 16.1
 Ho et al., 2008 23  
 Philpotts et al., 2000 23  
8-gauge stereotatic vacuum assisted biopsy
 Lee et al., 2013  9.09   
*11-gauge or 8-gauge stereotatic vacuum assisted biopsy
underestimated breast cancer and 20.0 mm for accurately 
diagnosed breast cancer (p>0.05). Relatively high BI-
RADS categories was assessed in accurately diagnosed 
breast cancer (p=0.01). Margin and orientation of mass 
on US and revealed statistically significant difference 
between two groups (p=0.01). There was no statistically 
significant difference in location and depth of the lesions 
and shape, echogenicity, combined calcifications and 
multiplicity on sonography in between underestimation 
and accurately diagnosed group.
 
Discussion
When diagnosing of breast masses visible with 
sonography, US-guided CNB could be gold standard, 
replacing needle localization open surgical biopsy (Youk 
et al., 2008). But, the CNB finding of ADH or DCIS is 
less reliable, due to histologic underestimation of breast 
malignancy.
Underestimation of ADH is an one of the important 
limitations of CNB. Pathologically, ADH is a borderline or 
high risk breast lesion, which fulfils some portion, but lacks 
meeting the strict criteria for DCIS. Comparing diagnostic 
criteria of DCIS, ADH is involved of a single duct or an 
aggregated diameter, less than 2mm and less extensive 
extension with same pathological findings labeling DCIS 
(Page et al., 1992; 1994). The underestimation rates 
of ADH and DCIS have been reported to be 6.25-65% 
and 16.1-66.7% at variable gauges US-guided biopsy 
or stereotactic biopsy (Table 4). And underestimations 
range from 23.1 to 65% for ADH and from 29 to 66.7% 
for DCIS diagnosed using US-guided 14-gauge CNB have 
been stated previously (Crystal et al., 2005; Jang et al., 
2008; Youk at al., 2008; Chae et al., 2009).
Between January 2007 and December 2009, 
percutaneous US-guided 14-gauge CNB was performed 
on 1898 consecutive breast lesions. Among them, CNB 
proven ADH (n=13) and DICS (n=27) were diagnosed. 
Previous findings show similar results or including ranges 
in our study with ADH underestimation rate of 53.8% (7 of 
13 lesions) and DCIS underestimation rate of 40.7% (11 of 
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our institution were only included in our study. 
We concluded that the underestimation of US-guided 
14G CNB occurred in 7.7% of breast cancers. Relatively 
lower BI-RADS category on underestimated breast cancer 
was described, compared with correctly diagnosed breast 
cancer and margin and orientation of mass on breast US or 
mammogram revealed statistically significant difference 
in comparison between two groups. 
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